Non-peptide
Methylcobalamin
Also known as
Methyl B12 · MeCbl · Vitamin B12 (methyl form)
Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.
What it is
| Identity | A form of vitamin B12, which supports blood cells and nerves. Being an active form does not establish superiority over other B12 forms. |
|---|---|
| Separate and combined products | Tablets, under-the-tongue products and injections differ from B12 added to compounded semaglutide or tirzepatide. A complete MIC shot also contains methionine, inositol and choline. |
Notes
One form of vitamin B12. B12 supports blood cells and nerves; treatment can correct deficiency. Methyl is an active form; the body also converts cyano and hydroxy forms. “Active” does not establish superiority. NIH ODS Vitamin B12 Health Professional Fact Sheet (Official context · Accessed 2026-09-30)
Tablets, under-the-tongue products and injections. Standalone methyl B12 differs from B12 inside compounded semaglutide or tirzepatide. It is not a peptide, NAD+, or a complete MIC shot containing methionine, inositol and choline.
Source context — NIH ODS Vitamin B12 Health Professional Fact Sheet: General B12 context, not methyl-specific dosing/half-life or a guarantee for fatigue.
What people notice
| Energy or no benefit | Some report fewer exhausted days or uplifting energy; another remained tired after twelve methyl injections over three months. |
|---|---|
| Nerve symptoms and memory | Reports include less burning or stabbing with benfotiamine co-use, and better memory with two B12 forms; neither isolates methyl's contribution. |
Notes
Less fatigue, sometimes without a buzz. A tirzepatide user reported fewer exhausted days with sublingual methyl plus multivitamins. Another described uplifting energy from injected methyl. Neither account establishes a general energy benefit. B12 Users... Does this really help with energy? (Community discussion · Accessed 2026-09-30) · B12 & Anxiety (Personal report · Accessed 2026-09-30)
Less fatigue for some, unchanged fatigue for another. The twelve-injection author remained sleepy and tired despite modafinil and vitamin D treatment. That contrasts with the sublingual methyl user reporting fewer tired days; neither explains every nonresponse. Am i fixed yet? (Personal report · Accessed 2026-09-30) · B12 Users... Does this really help with energy? (Community discussion · Accessed 2026-09-30)
Fewer nerve symptoms or clearer thinking. One tablet user described less burning and stabbing with methyl plus benfotiamine; a Phoenix Rising contributor described better memory with two B12 forms. Those combinations cannot isolate methyl’s contribution. Methylcobalamin and/or benfotiamine fixed my presumed SFN (Personal report · Accessed 2026-09-30) · Adenosyl and methylcobalamin injection dosage, page 2 (Personal report · Accessed 2026-09-30)
Source context — B12 Users... Does this really help with energy?: Only CICO-path specifies methyl form. Combined-product reports lack B12 form/component amounts and often include glycine. No added-B12 causal effectiveness conclusion.
Source context — B12 & Anxiety: Amounts and injection route unstated; cannot establish route superiority or general tolerability. OP's postpartum history is a confound, not a safety study.
Source context — Am i fixed yet?: Injection route and exact intervals unstated; no confirmed deficiency cause or objective improvement assessment; relative date only.
Source context — Methylcobalamin and/or benfotiamine fixed my presumed SFN: Oral tablet route inferred from author's named tablet product, not explicitly sublingual; two agents changed together; presumed condition, subjective estimates, no confirmed deficiency.
Source context — Adenosyl and methylcobalamin injection dosage, page 2: Combined B12 forms and vitamin D; self-described ME/CFS and genetics. No attribution to methyl alone, no long-term safety evidence.
Doses people talk about
| Oral and sublingual accounts | Separate reports include 1 mg orally, 2,000 mcg/day in tablets with benfotiamine, and 1,000 or 5,000 mcg under the tongue; the 5,000 mcg frequency is unstated. |
|---|---|
| Standalone injections | One account reports twelve 1,500 mcg methyl injections over three months. Another uses 5 mg methyl under the skin weekly plus 10 mg adenosyl every two weeks. |
| Combined-vial labels | Clinic menus list 1,000–2,000 mcg/mL methyl alongside tirzepatide concentrations; these are unverified concentrations, not delivered doses or a standard ratio. |
Notes
Oral: 1 mg; tablets: 2,000 mcg/day; sublingual: 1,000 or 5,000 mcg. These are separate accounts with different outcomes. The 2,000 mcg daily total was two 1,000 mcg tablets with benfotiamine; the 5,000 mcg thread author did not specify frequency. Methylcobalamin makes me very tired and sleepy (Personal report · Accessed 2026-09-30) · Methylcobalamin Side Effects? (Personal report · Accessed 2026-09-30) · Methylcobalamin and/or benfotiamine fixed my presumed SFN (Personal report · Accessed 2026-09-30)
Standalone methyl injections: 1,500 mcg per injection. One author reported twelve over three months without fatigue improvement. Separately, a subcutaneous account used 5 mg methyl weekly alongside 10 mg adenosyl every two weeks. Am i fixed yet? (Personal report · Accessed 2026-09-30) · Adenosyl and methylcobalamin injection dosage, page 2 (Personal report · Accessed 2026-09-30)
Johannes #34, February 17 2019: about 20 weeks, methyl 5 mg weekly and adenosyl 10 mg every two weeks; improved memory/language, persistent concentration limit, vitamin D change. #36 identifies subcutaneous use. Adenosyl and methylcobalamin injection dosage, page 2 (Personal report · Accessed 2026-09-30)
Combined-vial concentration is not a delivered dose. Earlier discussion listed tirzepatide 5–15 mg/mL with methyl 1,000–2,000 mcg/mL in clinic menus. These unverified concentrations are not a standard ratio; tirzepatide milligrams alone do not reveal B12 exposure.
Source context — Methylcobalamin makes me very tired and sleepy: One person with longstanding fatigue and stimulant co-use history; no verified deficiency or mechanism. Reply's biological theories not accepted.
Source context — Methylcobalamin Side Effects?: Anonymous reports; mixed forms, nutrients and deficiency histories; same-author follow-ups are not independent users.
Source context — Methylcobalamin and/or benfotiamine fixed my presumed SFN: Oral tablet route inferred from author's named tablet product, not explicitly sublingual; two agents changed together; presumed condition, subjective estimates, no confirmed deficiency.
Source context — Am i fixed yet?: Injection route and exact intervals unstated; no confirmed deficiency cause or objective improvement assessment; relative date only.
Source context — Adenosyl and methylcobalamin injection dosage, page 2: Combined B12 forms and vitamin D; self-described ME/CFS and genetics. No attribution to methyl alone, no long-term safety evidence.
Half-life, onset & duration
| Felt onset | One methyl-plus-benfotiamine account reports relief within two days; one sublingual user developed anxiety about four hours after 1,000 mcg. |
|---|---|
| Felt duration | No dependable single-dose window is established. Anxiety resolving about four days after stopping in one account describes symptom recovery, not clearance. |
| Half-life | No community measurement is established. About six days is repeated as background in a paper whose trial did not measure half-life. |
Notes
About four hours: one sublingual anxiety account. After 1,000 mcg, anxiety began that day and worsened after the next day’s dose. A different author using 5,000 mcg sublingually reported mood problems after two to three weeks. Methylcobalamin Side Effects? (Personal report · Accessed 2026-09-30)
Within two days: one combined tablet account. The methyl-plus-benfotiamine author reported substantial symptom relief, nearly complete by two weeks. Neither B12 deficiency nor the presumed nerve condition had been confirmed. Methylcobalamin and/or benfotiamine fixed my presumed SFN (Personal report · Accessed 2026-09-30)
About four days to anxiety resolution in one account. That follows stopping two daily 1,000 mcg sublingual doses after anxiety and paranoia worsened through day three. It is symptom recovery, not clearance. The combination-tablet author’s month without symptoms describes continued use, not one-dose duration. Methylcobalamin Side Effects? (Personal report · Accessed 2026-09-30) · Methylcobalamin and/or benfotiamine fixed my presumed SFN (Personal report · Accessed 2026-09-30)
No community-measured bodily half-life established. These accounts describe symptoms, intervals and breaks rather than measuring how quickly methylcobalamin leaves the body. Vitamin stores, blood levels and felt effects are different clocks. What b12 injections should I take for b12 130 pg/ml? (Personal report · Accessed 2026-09-30)
About six days is a repeated background claim. The same paper states that half-life in its discussion; its trial did not measure it. It is not a community timing measurement or a verified value for every formulation. Sil et al., methylcobalamin injection schedule comparison (Official context · Accessed 2026-09-30)
Source context — Methylcobalamin Side Effects?: Anonymous reports; mixed forms, nutrients and deficiency histories; same-author follow-ups are not independent users.
Source context — Methylcobalamin and/or benfotiamine fixed my presumed SFN: Oral tablet route inferred from author's named tablet product, not explicitly sublingual; two agents changed together; presumed condition, subjective estimates, no confirmed deficiency.
Source context — What b12 injections should I take for b12 130 pg/ml?: This commenter does NOT name B12 form or injection route. OP is 17; another adolescent writes 1500mg, which is not silently converted to mcg. Not an adult methylcobalamin regimen.
Source context — Sil et al., methylcobalamin injection schedule comparison: 24 neuropathy patients and 10 healthy controls; Wockhardt author affiliations. Background kinetics are repeated from references including commercial/monograph material; route-specific original PK not verified. PMC opens hit reCAPTCHA.
Cycles people discuss
| Reported use patterns | Daily tablets and repeated injections span weeks to months; maintenance calendars for other B12 forms do not automatically apply to methyl. |
|---|---|
| Stopping or reducing | One anxiety account improved after stopping; another's nerve symptoms returned when both methyl and benfotiamine were reduced. Neither defines a planned break. |
Notes
Daily tablets and repeated injections, rather than a shared cycle. Accounts span a month of tablets and three months of injections. Earlier daily oral, weekly GLP-additive and monthly injection patterns involve different products; cyano/hydroxy maintenance schedules do not transfer automatically to methyl. Methylcobalamin and/or benfotiamine fixed my presumed SFN (Personal report · Accessed 2026-09-30) · Am i fixed yet? (Personal report · Accessed 2026-09-30)
Stopping or reducing can bring different outcomes. The anxiety account improved after stopping. The nerve-symptom author reduced both supplements, relapsed within a day, then improved after restoring both. That does not establish a planned break or lifelong schedule. Methylcobalamin Side Effects? (Personal report · Accessed 2026-09-30) · Methylcobalamin and/or benfotiamine fixed my presumed SFN (Personal report · Accessed 2026-09-30)
Source context — Methylcobalamin and/or benfotiamine fixed my presumed SFN: Oral tablet route inferred from author's named tablet product, not explicitly sublingual; two agents changed together; presumed condition, subjective estimates, no confirmed deficiency.
Source context — Am i fixed yet?: Injection route and exact intervals unstated; no confirmed deficiency cause or objective improvement assessment; relative date only.
Source context — Methylcobalamin Side Effects?: Anonymous reports; mixed forms, nutrients and deficiency histories; same-author follow-ups are not independent users.
Stacks
| Methylation combinations | TMG, methylfolate, NAD+ and NMN appear in discussion; benfotiamine and other B12 forms accompany specific symptom reports. |
|---|---|
| GLP-1 and clinic combinations | Compounded semaglutide or tirzepatide, metformin-related B12 discussion and separate MIC shots appear in the original stack notes. |
Notes
“Methylation stacks” make attribution difficult. TMG, methylfolate, NAD+ and NMN appear in earlier discussions. Combined GLP products also complicate energy and weight-loss claims: a B12 add-in does not establish why the scale moved.
Fewer nerve symptoms or clearer thinking. One tablet user described less burning and stabbing with methyl plus benfotiamine; a Phoenix Rising contributor described better memory with two B12 forms. Those combinations cannot isolate methyl’s contribution. Methylcobalamin and/or benfotiamine fixed my presumed SFN (Personal report · Accessed 2026-09-30) · Adenosyl and methylcobalamin injection dosage, page 2 (Personal report · Accessed 2026-09-30)
Compounded semaglutide or tirzepatide: Combined-product reports may omit B12 form and amount and may include glycine. They do not isolate methylcobalamin benefit. [community]
+ Metformin: B12-depletion lore is why people add it. [community]
+ MIC (methionine, inositol, choline): Lipotropic clinic shot, separate from the GLP. [community]
Source context — Methylcobalamin and/or benfotiamine fixed my presumed SFN: Oral tablet route inferred from author's named tablet product, not explicitly sublingual; two agents changed together; presumed condition, subjective estimates, no confirmed deficiency.
Source context — Adenosyl and methylcobalamin injection dosage, page 2: Combined B12 forms and vitamin D; self-described ME/CFS and genetics. No attribution to methyl alone, no long-term safety evidence.
Watch for
| Mood, sleep and skin | Anxiety, insomnia, sleepiness, breakouts and rosacea flares are discussed. Symptoms do not establish a healing reaction or an overmethylation diagnosis. |
|---|---|
| Allergy | B12 contains cobalt; known cobalt allergy matters. Breathing difficulty, faintness or extensive blistering rash requires urgent care. |
| Deficiency assessment | Fatigue or a buzz alone cannot identify deficiency; metformin and acid suppressants can lower B12, and blood-marker interpretation needs context. |
| Compounded-product quality | Lilly reported an impurity in tested tirzepatide/B12 compounds; human consequences are unknown, and this does not establish the contents of every vial. |
Notes
Anxiety, insomnia and sleepiness all occur in reports. The 5,000 mcg author slept better despite worse mood; the LongeCity user became sleepier. Symptoms are not proof of healing or a measured “overmethylation” diagnosis. Methylcobalamin Side Effects? (Personal report · Accessed 2026-09-30) · Methylcobalamin makes me very tired and sleepy (Personal report · Accessed 2026-09-30)
Breakouts and rosacea remain relevant cautions. Earlier accounts mention skin flares. A newer combined B12/glycine user described energy with severe breakouts, then fatigue after switching to B6; the B12 form was unstated. B12 Users... Does this really help with energy? (Community discussion · Accessed 2026-09-30)
Cobalt allergy and severe reactions need attention. B12 contains cobalt. MHRA’s notice concerns hydroxy/cyano medicines; known allergy warrants professional discussion. Breathing difficulty, faintness or extensive blistering rash requires urgent care. Vitamin B12 and cobalt sensitivity (Official context · Accessed 2026-09-30)
Deficiency treatment needs more than an energy score. NIH describes MMA, a B12-related blood marker affected by kidney function, and the less-specific homocysteine test. Metformin and acid suppressants can lower B12; fatigue alone cannot identify deficiency. NIH ODS Vitamin B12 Health Professional Fact Sheet (Official context · Accessed 2026-09-30)
Bloodwork and diet questions are part of the discussion. Community notes ask about apparently normal serum B12, MMA and homocysteine, especially with metformin or limited dietary B12. A buzz, tingling change or high supplemented blood level alone does not settle deficiency.
Mixed tirzepatide/B12 has separate quality questions. Lilly reported a reaction-created impurity in tested compounded products in March 2026; human consequences remain unknown. This is the manufacturer’s warning, not proof about every vial or separate B12 tablets. Lilly open letter on tirzepatide compounded with B12 (Official context · Accessed 2026-09-30)
Source context — Methylcobalamin Side Effects?: Anonymous reports; mixed forms, nutrients and deficiency histories; same-author follow-ups are not independent users.
Source context — Methylcobalamin makes me very tired and sleepy: One person with longstanding fatigue and stimulant co-use history; no verified deficiency or mechanism. Reply's biological theories not accepted.
Source context — B12 Users... Does this really help with energy?: Only CICO-path specifies methyl form. Combined-product reports lack B12 form/component amounts and often include glycine. No added-B12 causal effectiveness conclusion.
Source context — Vitamin B12 and cobalt sensitivity: Notice explicitly concerns hydroxocobalamin and cyanocobalamin medicines; no methyl-specific incidence estimate.
Source context — NIH ODS Vitamin B12 Health Professional Fact Sheet: General B12 context, not methyl-specific dosing/half-life or a guarantee for fatigue.
Source context — Lilly open letter on tirzepatide compounded with B12: Commercial manufacturer and competitor to compounders; primary corporate testing statement, not independent incidence or proof every vial has this impurity.
Full notes
Methylcobalamin is a form of vitamin B12 discussed for fatigue, nerve symptoms and methylation stacks, and as an add-in to compounded GLP-1 products. Experiences include better energy, no benefit, anxiety and sleepiness. Form, route, deficiency status and other ingredients complicate comparisons.
What methylcobalamin is
- One form of vitamin B12. B12 supports blood cells and nerves; treatment can correct deficiency. Methyl is an active form; the body also converts cyano and hydroxy forms. “Active” does not establish superiority. Official context
- Tablets, under-the-tongue products and injections. Standalone methyl B12 differs from B12 inside compounded semaglutide or tirzepatide. It is not a peptide, NAD+, or a complete MIC shot containing methionine, inositol and choline. Community
What people hope to get
- Less fatigue, sometimes without a buzz. A tirzepatide user reported fewer exhausted days with sublingual methyl plus multivitamins. Another described uplifting energy from injected methyl. Neither account establishes a general energy benefit. Reddit r/tirzepatidecompound Personal report
- Fewer nerve symptoms or clearer thinking. One tablet user described less burning and stabbing with methyl plus benfotiamine; a Phoenix Rising contributor described better memory with two B12 forms. Those combinations cannot isolate methyl’s contribution. Personal report Personal report
Doses people report
- Oral: 1 mg; tablets: 2,000 mcg/day; sublingual: 1,000 or 5,000 mcg. These are separate accounts with different outcomes. The 2,000 mcg daily total was two 1,000 mcg tablets with benfotiamine; the 5,000 mcg thread author did not specify frequency. Personal report Personal report Personal report
- Standalone methyl injections: 1,500 mcg per injection. One author reported twelve over three months without fatigue improvement. Separately, a subcutaneous account used 5 mg methyl weekly alongside 10 mg adenosyl every two weeks. Personal report Personal report
- 500, 1,000 and 1,500 mcg: B12 form unstated. The commenter comparing these injection amounts perceived little difference by amount. Their report is useful B12 discussion, but it cannot establish a methyl-specific dose. Personal report
- Combined-vial concentration is not a delivered dose. Earlier discussion listed tirzepatide 5–15 mg/mL with methyl 1,000–2,000 mcg/mL in clinic menus. These unverified concentrations are not a standard ratio; tirzepatide milligrams alone do not reveal B12 exposure. Community
Half-life in community discussion
- No community-measured bodily half-life established. These accounts describe symptoms, intervals and breaks rather than measuring how quickly methylcobalamin leaves the body. Vitamin stores, blood levels and felt effects are different clocks. Community Personal report
When people notice a change
- About four hours: one sublingual anxiety account. After 1,000 mcg, anxiety began that day and worsened after the next day’s dose. A different author using 5,000 mcg sublingually reported mood problems after two to three weeks. Personal report
- Within two days: one combined tablet account. The methyl-plus-benfotiamine author reported substantial symptom relief, nearly complete by two weeks. Neither B12 deficiency nor the presumed nerve condition had been confirmed. Personal report
How long changes seem to last
- About four days to anxiety resolution in one account. That follows stopping two daily 1,000 mcg sublingual doses after anxiety and paranoia worsened through day three. It is symptom recovery, not clearance. The combination-tablet author’s month without symptoms describes continued use, not one-dose duration. Personal report Personal report
Courses and breaks people describe
- Daily tablets and repeated injections, rather than a shared cycle. Accounts span a month of tablets and three months of injections. Earlier daily oral, weekly GLP-additive and monthly injection patterns involve different products; cyano/hydroxy maintenance schedules do not transfer automatically to methyl. Personal report Personal report Community
- Stopping or reducing can bring different outcomes. The anxiety account improved after stopping. The nerve-symptom author reduced both supplements, relapsed within a day, then improved after restoring both. That does not establish a planned break or lifelong schedule. Personal report Personal report
What to watch for
- Anxiety, insomnia and sleepiness all occur in reports. The 5,000 mcg author slept better despite worse mood; the LongeCity user became sleepier. Symptoms are not proof of healing or a measured “overmethylation” diagnosis. Personal report Personal report
- Breakouts and rosacea remain relevant cautions. Earlier accounts mention skin flares. A newer combined B12/glycine user described energy with severe breakouts, then fatigue after switching to B6; the B12 form was unstated. Community Reddit r/tirzepatidecompound
- Cobalt allergy and severe reactions need attention. B12 contains cobalt. MHRA’s notice concerns hydroxy/cyano medicines; known allergy warrants professional discussion. Breathing difficulty, faintness or extensive blistering rash requires urgent care. Official context
- Deficiency treatment needs more than an energy score. NIH describes MMA, a B12-related blood marker affected by kidney function, and the less-specific homocysteine test. Metformin and acid suppressants can lower B12; fatigue alone cannot identify deficiency. Official context
- Folate, iron and potassium concerns are treatment context. Cyanocobalamin labeling warns about low potassium during intensive treatment of severe megaloblastic anemia and missed folate deficiency. These are clinical monitoring issues, not a reason to copy a supplement stack. Official context
- Mixed tirzepatide/B12 has separate quality questions. Lilly reported a reaction-created impurity in tested compounded products in March 2026; human consequences remain unknown. This is the manufacturer’s warning, not proof about every vial or separate B12 tablets. Official context
- Storage and color cannot certify quality. Earlier reports discuss dry tablets, light-protected solutions and pharmacy-specific freezing instructions. Actual product instructions govern. Pink color or red urine should not be treated as proof of purity or harmlessness. Community
What the experiences add
- Form debates also involve marketing. Earlier MTHFR discussions favored “active” methyl and called cyano cheaper and more stable in vials. Those forum comparisons do not resolve the mixed personal responses to different forms. Community Personal report
- Less fatigue for some, unchanged fatigue for another. The twelve-injection author remained sleepy and tired despite modafinil and vitamin D treatment. That contrasts with the sublingual methyl user reporting fewer tired days; neither explains every nonresponse. Personal report Reddit r/tirzepatidecompound
- Route can matter to the experience without proving superiority. The September 2026 contributor reported oral/sublingual jitters but comfortable injected energy. No amount was supplied. Another person’s injection experience cannot predict the same switch for everyone. Personal report
- A form switch can have a later reversal. One earlier methyl user described anxiety while nerve symptoms improved, then later reported better results with weekly cyanocobalamin injections and symptom return when stopping. Another favored hydroxy up to 2,000 mcg over nine months but had no retest. Personal report
- Spacing mattered in one unspecified-form injection story. Symptoms worsened when two-day intervals became three to five days, despite little perceived difference between amounts. This is subjective experience, not a half-life calculation. Personal report
- “Methylation stacks” make attribution difficult. TMG, methylfolate, NAD+ and NMN appear in earlier discussions. Combined GLP products also complicate energy and weight-loss claims: a B12 add-in does not establish why the scale moved. Community Community
- Bloodwork and diet questions are part of the discussion. Community notes ask about apparently normal serum B12, MMA and homocysteine, especially with metformin or limited dietary B12. A buzz, tingling change or high supplemented blood level alone does not settle deficiency. Community
Separate clinical context
- 500 mcg IM three times weekly versus 1,500 mcg IM weekly. Sil and colleagues compared these over two weeks in neuropathy patients. Blood B12 rose more with the divided schedule; this does not establish a biohacking cycle. Official context
- About six days is a repeated background claim. The same paper states that half-life in its discussion; its trial did not measure it. It is not a community timing measurement or a verified value for every formulation. Official context
- Pregnancy and nursing change the context. B12 is essential, but high-dose methyl and combined-product anecdotes do not establish pregnancy safety. Nascobal’s labeling concerns a different B12 medicine. Official context